Diversified Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Buy |
8,109
+23
| +0.3% | +$5.55K | 0.04% | 240 |
|
|
2025
Q1 | $1.97M | Buy |
8,086
+5,170
| +177% | +$1.26M | 0.05% | 213 |
|
|
2024
Q4 | $958K | Buy |
+2,916
| New | +$958K | 0.02% | 377 |
|
|
2024
Q2 | – | Sell |
-5,957
| Closed | -$2.06M | – | 885 |
|
|
2024
Q1 | $2.06M | Buy |
5,957
+4,299
| +259% | +$1.49M | 0.06% | 187 |
|
|
2023
Q4 | $535K | Buy |
1,658
+143
| +9% | +$46.2K | 0.02% | 484 |
|
|
2023
Q3 | $543K | Sell |
1,515
-1,049
| -41% | -$376K | 0.02% | 436 |
|
|
2023
Q2 | $972K | Sell |
2,564
-23
| -0.9% | -$8.72K | 0.04% | 284 |
|
|
2023
Q1 | $1.24M | Sell |
2,587
-893
| -26% | -$428K | 0.05% | 217 |
|
|
2022
Q4 | $1.46M | Sell |
3,480
-330
| -9% | -$139K | 0.06% | 172 |
|
|
2022
Q3 | $1.59M | Buy |
3,810
+302
| +9% | +$126K | 0.07% | 137 |
|
|
2022
Q2 | $1.74M | Buy |
3,508
+235
| +7% | +$116K | 0.07% | 137 |
|
|
2022
Q1 | $1.84M | Buy |
3,273
+859
| +36% | +$484K | 0.06% | 150 |
|
|
2021
Q4 | $1.82M | Buy |
2,414
+87
| +4% | +$65.7K | 0.06% | 157 |
|
|
2021
Q3 | $1.74M | Sell |
2,327
-145
| -6% | -$108K | 0.06% | 154 |
|
|
2021
Q2 | $1.59M | Buy |
2,472
+414
| +20% | +$267K | 0.06% | 159 |
|
|
2021
Q1 | $1.18M | Buy |
2,058
+702
| +52% | +$401K | 0.05% | 192 |
|
|
2020
Q4 | $790K | Buy |
1,356
+212
| +19% | +$124K | 0.03% | 247 |
|
|
2020
Q3 | $590K | Buy |
1,144
+35
| +3% | +$18.1K | 0.03% | 273 |
|
|
2020
Q2 | $501K | Buy |
+1,109
| New | +$501K | 0.03% | 255 |
|
|
2014
Q2 | $946K | Buy |
+7,905
| New | +$946K | 0.08% | 263 |
|
|
2013
Q4 | $1.18M | Hold |
9,525
| – | – | 0.12% | 170 |
|
|
2013
Q3 | $1.12M | Buy |
9,525
+60
| +0.6% | +$7.06K | 0.12% | 183 |
|
|
2013
Q2 | $1.06M | Buy |
+9,465
| New | +$1.06M | 0.13% | 166 |
|